Cross-reactive primers for amplifying the nucleic acids of...

Details Cross-reactive primers for amplifying the nucleic acids of... Cross-reactive primers for amplifying the nucleic acids of...

2007-08-13

2010-02-23

Parkin, Jeffrey S (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C536S023100, C536S023720, C536S024300, C536S024320, C536S024330

Reexamination Certificate

active

07666600

ABSTRACT:
Compositions, methods and kits for detecting the nucleic acids of HIV-1, HIV-2, or the combination of HIV-1 and HIV-2. Particularly described are oligonucleotides that are useful as hybridization probes and amplification primers, including cross-reacting hybridization probes and cross-reacting amplification primers, for detecting very low levels of viral nucleic acids.

REFERENCES:
patent: 5283174 (1994-02-01), Arnold, Jr. et al.
patent: 5310651 (1994-05-01), Alizon et al.
patent: 5399491 (1995-03-01), Kacian et al.
patent: 5599662 (1997-02-01), Respess
patent: 5688637 (1997-11-01), Moncany et al.
patent: 5712385 (1998-01-01), McDonough et al.
patent: 5786177 (1998-07-01), Moncany et al.
patent: 5827648 (1998-10-01), Eastman et al.
patent: 5856088 (1999-01-01), McDonough et al.
patent: 5866319 (1999-02-01), Alizon et al.
patent: 5962665 (1999-10-01), Kroeger et al.
patent: 6001558 (1999-12-01), Backus et al.
patent: 6031091 (2000-02-01), Arnold, Jr. et al.
patent: 6187538 (2001-02-01), Eastman et al.
patent: 6232455 (2001-05-01), Kroeger et al.
patent: 6277561 (2001-08-01), Guertler et al.
patent: 6303293 (2001-10-01), Patterson et al.
patent: 6316183 (2001-11-01), Alizon et al.
patent: 6335158 (2002-01-01), Brust et al.
patent: 6610476 (2003-08-01), Chang et al.
patent: 6623920 (2003-09-01), Bee et al.
patent: 2003/0049604 (2003-03-01), Charneau et al.
patent: 2003/0091985 (2003-05-01), Alizon et al.
patent: 2003/0186219 (2003-10-01), Alizon et al.
patent: 2003/0235835 (2003-12-01), Alizon et al.
patent: 0 736 600 (1996-10-01), None
patent: 0 504 278 (1997-01-01), None
patent: 0 887 427 (1998-12-01), None
patent: 1 026 263 (2000-08-01), None
patent: 1 035 220 (2000-09-01), None
patent: 1 223 227 (2002-07-01), None
patent: 1 344 837 (2003-09-01), None
patent: 1 422 298 (2004-05-01), None
patent: WO 9216180 (1992-10-01), None
patent: WO 98/58086 (1998-12-01), None
patent: WO 01/04361 (2001-01-01), None
patent: WO 02055741 (2002-07-01), None
Abravaya et al., “Performance of a Multiplex Qualitative PCR LCx Assay for Detection of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Subtypes, Group O, and HIV-2”,J. Clin. Microbiology, 2000, 38(2):716-723, ASM, Washington D.C., USA.
Damond et al., “Quantification of Proviral Load of Human Immunodeficiency Virus Type 2 Subtypes A and B Using Real-Time PCR”,J. Clin. Microbiology, 2001, 39(12):4264-4268, ASM, Washington D.C. USA.
Giachetti et al., “Highly Sensitive Multiplex Assay for Detection of Human Immunoceficiency Virus Type 1 and Hepatitis C Virus RNA”, J. Clin. Microbiol., Jul. 2002, 40(7):2408-2419, ASM, USA.
McDonough et al., “High Throughput Assay for the Simultaneous or Separate Detection of Human Immunodeficiency Virus (HIV) and Hepatitis Type C Virus (HCV)”, Infusionsther Transfusionsmed, 1998, 25:164-169, Karger, Basel.
Masciotra et al., “Detection of Simian Immunodeficiency Virus in Diverse Species and or Human Immunodeficiency Virus Type 2 by Using Consensus Primers within thepolRegion”,J. Clin. Microbiology, 2002, 40(9):3167-3171, ASM, Washington D.C. USA.
Morandi et al., “Detection of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Pools of Sera Negative for Antibodies to HIV-1 and HIV-2”,J. Clin. Microbiology, 1998, 36(6):1534-1538, ASM, Washington, D.C. USA.
Nazábal et al., “Deteccion Directa De La Infeccion Por VIH 1 Y VIH 2 En Individuos Seropositivos Mediante La Amplificacion Del Adn”, Biotechnologia Aplicada, 1998, 10(2):129-132, Sociedad Iberolatinoamericana de Biotechnolgio Aplienda a la Salud, La Habana, Cuba (summary in English).
Nedjar et al., “Co-amplification of specific sequences of HCV and HIV-1 genomes by using the polymerase chain reaction assay: a potential tool for the simultaneous detection of HCV and HIV-1”, J. Virol. Methods, 1991, 35:297-304, Elsevier Science B.V., Amsterdam, Netherlands.
Pieniazek et al., “Identification of mixed HIV-1/HIV-2 infections in Brazil by polymerase chain reaction”, AIDS, 1991, 5(11):1293-1299, Current Science, USA.
Pyra et al., “Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement”,Proc. Natl. Acad. Sci., 1994, 91:1544-1548, USA.
Rouet et al., “Field Evaluation of a Rapid Human Immunodeficiency Virus (HIV) Serial Serologic Testing Algorithm for Diagnosis and Differentiation of HIV Type 1 (HIV-1), HIV-2, and Dual HIV-1-HIV-2, Infections in West African Pregnant Women”,J. Clin. Microbiology, 42(9):4147-4153, ASM, Washington, D.C. USA.
Vet et al. “Multiplex detection of four pathogenic retroviruses using molecular beacons”,Proc. Natl. Acad. Sci., 1999, 96:6394-6399, USA.
Weber et al., “Reduction of Diagnostic Window by New Fourth-Generation Human Immunodeficiency Virus Screening Assays”,J. Clin. Microbiology, 1998, 36(8):2235-2239, ASM, Washington D.C. USA.

Affiliated with

Also associated with

Rating

Cross-reactive primers for amplifying the nucleic acids of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cross-reactive primers for amplifying the nucleic acids of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-reactive primers for amplifying the nucleic acids of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4153711